
### [NCIT:C5584](http://purl.obolibrary.org/obo/NCIT_C5584)
**Label:** Stage IV Skin Cancer

**Subclasses:** [NCIT:C8209](http://purl.obolibrary.org/obo/NCIT_C8209) (Stage IV Lip Basal Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C47805](http://purl.obolibrary.org/obo/NCIT_C47805) (Malignant Neuroendocrine Small Round Cell) 53.57%
- [NCIT:C27971](http://purl.obolibrary.org/obo/NCIT_C27971) (Stage IV) 53.57%
- Thing 53.00%
- [NCIT:C60534](http://purl.obolibrary.org/obo/NCIT_C60534) (Neoplastic Neuroendocrine Small Cell) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 38.93%
- [NCIT:C36820](http://purl.obolibrary.org/obo/NCIT_C36820) (Malignant Neuroendocrine Small Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 38.93%


